secobarbital will lower the level or effect of mavacamten by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Contraindicated.The effect with the resultant lowered blood levels of griseofulvin on therapeutic response hasn't been proven. Having said that, It will be preferable to stop concomitant administration of those drugs.We publish subs